Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on November 13, 2019. The filing serves to announce the Company's financial results for the quarter ended September 30, 2019. The report includes a press release and a letter to stockholders as Exhibits 99.1 and 99.2, respectively.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached Exhibits 99.1 and 99.2, which are not included in the source text.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period within the main body text. It directs readers to the furnished press release and stockholder letter for the specific operational and financial comparisons.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished under Item 2.02, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act. Consequently, the Company does not assume any obligation to update such information in the future. No specific guidance, outlook, or risk factors are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2019 revenue and earnings figures.
- Review Exhibit 99.2 (Letter to Stockholders) for management commentary on operational performance.
- Verify the Company's liquidity position and cash burn rate as detailed in the full financial statements referenced in the exhibits.
- Confirm any forward-looking guidance provided in the press release, noting the disclaimer regarding future updates.